Visalytics
Visalytics
approved EB-2 (NIW)

PhD Student

Computer Science · China · 2026-02-21

Processing Time
317 days
Decision Date
2026-02-21
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop advanced deep learning models to improve the understanding of structure-function relationships in large biomolecules. This work aims to enable more accurate target identification, better candidate design, and more efficient therapeutic optimization for complex diseases. The endeavor specifically targets bottlenecks in drug development to reduce the high failure rate and cost of new drug candidates.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor targets a real bottleneck in therapeutic development and addresses the U.S. burden of chronic disease and high drug candidate failure rates.

2 Well-positioned to Advance the Endeavor Met

The petitioner demonstrated a track record of execution through peer-reviewed publications, 82 citations, and 17 completed peer reviews.

3 Waiver of Job Offer and Labor Certification Met

The case presented a compelling chain of evidence showing the researcher is already influencing the field through selective publication and independent reliance.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 2 journal articles, 4 conference articles, and 82 citations, demonstrating independent reliance by the scientific community. Additionally, the petitioner completed 17 peer reviews for authoritative conferences, signaling high standing in the field. All three Dhanasar prongs were satisfied by linking AI expertise to the national priority of reducing drug development costs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Judging Experience
Original Contributions

Similar Cases

Chief Executive Officer (CEO)

Artificial Intelligence · Syria

WeGreened EB-2 (NIW) approved
200 days 2025-06-25
The petitioner proposes to lead scientific initiatives building machine learning models that accelerate the drug discovery process, specifically focusing on simulating molecular interactions to design personalized cancer treatments. Her work aims to address bottlenecks in drug development by blending multi-omics data with predictive AI systems to reduce costs and increase precision.
View Case

Consultant

Engineering · India

WeGreened EB-2 (NIW) approved
New Jersey 45 days 2025-01-16
The petitioner proposes to continue research on developing advanced machine learning, artificial intelligence, and language modeling frameworks by integrating data-driven methods with domain knowledge. This work aims to address key challenges in drug development and healthcare, specifically focusing on accelerating drug discovery, optimizing clinical trials, and enhancing manufacturing efficiency.
View Case

Research Assistant

Artificial Intelligence · Bangladesh

WeGreened EB-2 (NIW) approved
South Carolina 344 days 2025-06-03
The petitioner proposes to develop advanced AI models, specifically graph neural networks and deep learning architectures, for predicting drug-target interactions and optimizing drug compounds. This work aims to revolutionize drug discovery, accelerate molecular simulations, and facilitate the identification of crystal structures for pharmaceutical and optoelectronic applications.
View Case

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
California 4 days 2025-08-08
The petitioner proposes to develop and apply advanced machine learning and computational chemistry methods to predict molecular properties with high accuracy. This work focuses on the targeted design of novel molecules to accelerate drug discovery and reduce the high costs and failure rates associated with therapeutic development.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Information Technology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2026-02-21.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 317 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist